XML 26 R5.htm IDEA: XBRL DOCUMENT v3.20.4
STATEMENTS OF REDEEMABLE PREFERRED STOCK AND STOCKHOLDERS' EQUITY (DEFICIT) - USD ($)
shares in Thousands, $ in Thousands
Common Stock
Additional Paid-in Capital
Accumulated Deficit
Series B1 Redeemable Convertible Preferred Stock
Total
Beginning balance at Dec. 31, 2017 $ 24 $ 712,165 $ (604,494)   $ 107,695
Beginning balance (in shares) at Dec. 31, 2017 24,453        
Issuance of common stock under employee stock purchase plan   243     243
Issuance of common stock under employee stock purchase plan (in shares) 25        
Issuance of common stock upon exercise of common stock options and warrants $ 3 10,163     10,166
Issuance of common stock upon exercise of common stock options and warrants (in shares) 2,702        
Issuance of common stock for services rendered   97     97
Issuance of common stock for services rendered (in shares) 8        
Stock-based compensation expense   5,674     5,674
Net loss     (59,881)   (59,881)
Ending balance at Dec. 31, 2018 $ 27 728,342 (664,375)   63,994
Ending balance (in shares) at Dec. 31, 2018 27,188        
Sale of common stock, net of issuance costs $ 3 5,295     5,298
Sale of common stock, net of issuance costs (in shares) 2,068        
Sale of redeemable convertible preferred stock       24  
Deemed dividend related to December 2019 Private Placement (Note 7)   (28,043)     (28,043)
Issuance of commitment shares (in shares) 270        
Issuance of common stock under employee stock purchase plan   121     121
Issuance of common stock under employee stock purchase plan (in shares) 61        
Issuance of common stock upon exercise of common stock options and warrants   3     3
Issuance of common stock upon exercise of common stock options and warrants (in shares) 38        
Issuance of common stock for services rendered   129     129
Issuance of common stock for services rendered (in shares) 47        
Stock-based compensation expense   3,845     3,845
Net loss     (56,515)   (56,515)
Ending balance at Dec. 31, 2019 $ 30 709,692 (720,890)   $ (11,168)
Ending balance (in shares) at Dec. 31, 2019 29,672     24 29,672
Sale of common stock, net of issuance costs $ 8 28,638     $ 28,646
Sale of common stock, net of issuance costs (in shares) 8,218        
Issuance of common stock under equity incentive plan (vesting of restricted stock units) (in shares) 177        
Issuance of common stock under employee stock purchase plan   113     113
Issuance of common stock under employee stock purchase plan (in shares) 76        
Issuance of common stock upon exercise of warrants   15     15
Issuance of common stock upon exercise of warrants (in shares) 5        
Issuance of common stock for services rendered   243     243
Issuance of common stock for services rendered (in shares) 143        
Stock-based compensation expense   3,641     3,641
Net loss     (112,662)   (112,662)
Ending balance at Dec. 31, 2020 $ 38 $ 742,342 $ (833,552)   $ (91,172)
Ending balance (in shares) at Dec. 31, 2020 38,291     24 38,291